实时三维超声造影在肝癌射频消融术前形态评估中的应用价值
本研究回顾性分析60例肝癌患者88个目标病灶,比较实时三维超声造影(RT-3D-CEUS)与常规超声造影(CEUS)在射频消融(RFA)术前评估病灶大小和形态的能力,并以术后3个月肿瘤残留为参考标准。结果显示RT-3D-CEUS测量的病灶更大、识别不规则形态更多,且两种方法测量大小或形态不一致的病灶术后残留率显著更高。
要点
- RT-3D-CEUS较CEUS更易发现病灶更大及形态不规则。
- 两种方法测量大小不一致的病灶RFA后残留率更高(33.3% vs 5.7%,P=0.004)。
- 两种方法形态评估不一致的病灶残留率亦更高(40.0% vs 7.7%,P=0.012)。
核心结论
- RT-3D-CEUS能更准确地描述肝癌病灶的大小和形态,且病灶形态学特征与RFA术后肿瘤残留相关。
研究设计与样本
- 回顾性分析60例接受RFA治疗的肝癌患者共88个目标病灶的术前CEUS和RT-3D-CEUS影像资料。
主要发现
- 88个病灶中70个两种方法测量大小相当(A组),18个RT-3D-CEUS测量更大(B组)。
- CEUS显示类圆形38个、椭圆形47个、不规则形3个;RT-3D-CEUS显示类圆形34个、椭圆形41个、不规则形13个。
- 78个病灶两种方法形态评估一致(A′组),10个不一致(B′组)。
- 术后3个月复查,A组残留4个(5.7%),B组残留6个(33.3%),差异有统计学意义(P=0.004)。
- A′组残留6个(7.7%),B′组残留4个(40.0%),差异有统计学意义(P=0.012)。
临床怎么用
- RFA术前可采用RT-3D-CEUS评估肝癌病灶大小和形态,辅助预判术后残留风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the evaluating ability of real-time three-dimensional contrast-enhanced ultrasound (RT-3D-CEUS) for morphology of hepatocellular carcinoma (HCC) before radiofrequency ablation (RFA) treatment. Methods: Sixty patients with 88 targeted lesions were enroll in this study, who have received RFA in Hangzhou Xiasha Hospital. The pretreatment imaging data of CEUS and RT-3D-CEUS were retrospective analysis. Morphological features were assessed according to the size and shape of the lesions, and were compared between two modalities with the post-treatment response as the reference standard. Results: The size of lesion measured by CEUS and RT-3D-CEUS was similar in 70 out of 88 lesions (group A). In the other 18 lesions, the size measured by RT-3D-CEUS was larger than that by CEUS (group B). For the shape analysis, 38 lesions were spheroid by CEUS and 34 lesions by RT-3D-CEUS; 47 lesions were oval by CEUS and 41 lesions by RT-3D-CEUS; 3 lesions were irregular by CEUS and 13 lesions by RT-3D-CEUS. There were 78 lesions which shape assessed by two modalities consistently (group A'), and the other 10 lesions with inconsistent shape by two modalities (group B'). Three months follow-up results showed that 4 lesions appeared tumor residue (5.7%) in group A' and 6 lesions (33.3%) in group B'. There was significant difference between these two groups (P=0.004). In the group A', there were 6 lesions (7.7%) showed tumor residue, and 4 lesions (40.0%) in group B'. The difference between these two groups was also significant (P=0.012). Conclusion: RT-3D-CEUS could be used to assess the size and shape of HCC accurately which is associated with the response of RFA. 目的: 探讨实时三维超声造影(RT-3D-CEUS)在肝癌射频消融(RFA)术前对病灶形态的评估能力。 方法: 选择在杭州市下沙医院接受RFA治疗的60例肝癌患者(88个目标病灶)为研究对象,对其术前超声造影(CEUS)和RT-3D-CEUS资料进行回顾性分析,通过观察病灶的大小和形态,比较两种检查显示病灶形态学特征的能力,并与术后肿瘤发生残留情况进行对比分析。 结果: 在入选的88个目标病灶中,有70个CEUS测量病灶大小与RT-3D-CEUS相当(A组),另外18个RT-3D-CEUS测量的病灶大小较CEUS更大(B组)。CEUS显示病灶为类圆形38个,椭圆形47个,不规则形3个。而RT-3D-CEUS显示病灶为类圆形34个,椭圆形41个,不规则形13个。其中78个CEUS与RT-3D-CEUS显示病灶形态一致(A′组),另外10个病灶两种检查方法显示病灶形态不一致(B′组)。与术后3个月复查结果比较,A组病灶中经RFA治疗后仍有4个(5.7%)病灶肿瘤残留,而B组中有6个(33.3%)病灶残留,两组病灶肿瘤残留率之间的差异有统计学意义(P=0.004)。A′组病灶中经RFA治疗后仍有6个(7.7%)病灶肿瘤残留,而B′组中有4个(40.0%)病灶残留,两组病灶肿瘤残留率之间的差异有统计学意义(P=0.012)。 结论: RT-3D-CEUS可以从大小和形态方面对肝癌病灶的形态学特征进行更为准确地描述,病灶的形态学特征对其RFA术后肿瘤残留有一定影响。.
引用
- Wang XC, Li SY, Fang Y, et al. [Application value of real-time three-dimensional contrast-enhanced ultrasound for morphological assessing of hepatocellular carcinoma before radiofrequency ablation treatment]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 29575843. doi:10.3760/cma.j.issn.0253-3766.2018.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。